Cellectar announces FDA grants exemption to import alert for CLR 131 hematology studies
Cellectar Biosciences announces the FDA has granted an exemption to the Import Alert placed on the Centre for Probe Development and Commercialization, the sole supplier of the CLR 131. The exemption for CLR 131 is effective immediately for all hematology studies. November 12, 2018